NovoCure Ltd — Director's Dealing 2017

Nov 8, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2017-11-06

Reporting Person: Kirson Eilon D. (Chief Science Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-11-06	Ordinary Shares	S	9100	$22.00	Disposed	28501	Direct

Footnotes

F1: These shares were sold pursuant to a Rule 10b5-1 trading plan adopted by Mr. Kirson.